International Stem Cell Corporation, (ISCO, www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product.

Via Jacob Blumenthal